12 results
S-3
EX-1.2
TRML
Tourmaline Bio Inc
15 Aug 22
Shelf registration
5:06pm
and Prospectus satisfies the independence standards established by Nasdaq and, with respect to members of the Company’s audit committee, the enhanced … independence standards contained in Rule 10A-3(b)(1) promulgated by the Commission under the Exchange Act.
(zz) Each financial or operational
8-K
mazd r1t49vb4mzei
17 May 22
Talaris Therapeutics Announces Changes to Board of Directors
8:29am
DEF 14A
9coqhbikkduw
29 Apr 22
Definitive proxy
4:24pm
10-K
zk4p5
17 Mar 22
Annual report
4:31pm
424B4
zt7pqqbv1y1m
10 May 21
Prospectus supplement with pricing info
4:20pm
S-1/A
i8e2vb5o6bazuerd9
3 May 21
IPO registration (amended)
6:07am
S-1
850b8t aen2w5
16 Apr 21
IPO registration
5:03pm
DRS/A
m6ydq
1 Apr 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next